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Background: 
Drug utilisation research contributes to rational use of medicines by optimising prescribing, including 
acute conditions such as upper respiratory tract infections or insomnia and anxiety. Pharmacotherapy 
should not be used as first-line treatment for insomnia and anxiety, and benzodiazepines should 
always be prescribed with caution due to their potential for addiction. Antibiotics must be prescribed 
with due diligence to reduce antimicrobial resistance, and the prescribing of antibiotics and 
benzodiazepines should follow local guidelines. 
 
Objectives: 
The primary objective was to develop a dataset of de-identified dispensing data in Australia that would 
be suitable for drug utilization research. The secondary objectives were to analyse two subsets of 
data - antimicrobials and benzodiazepines - to identify possible medication misuse and to facilitate 
cross-national comparison. 
 
Methods: 
Customised software was used to extract and de-identify dispensing data from three pharmacies in 
South East Queensland using protocols approved by an ethics committee at the University of 
Queensland, Australia. The South African data were obtained from a private medical insurance 
scheme following ethical approval from Nelson Mandela Metropolitan University (South Africa) and 
both datasets were analysed using retrospective drug utilization techniques. 
 
Results: 
Cross-national comparison of benzodiazepines showed a high frequency of alprazolam prescribing in 
South Africa; the drug was recently rescheduled to Controlled Drug status in Australia due to its 
potential for abuse. Trends in ‘repeat’ dispensing of antibiotics in the Australian dataset were cause 
for concern and nearly one-tenth of antibiotics were dispensed 30 days after prescribing. 
 
Conclusions: 
Software designed collaboratively by Kairuz, Pudmenzky, Rossato and Fredericks was suitable for 
drug utilisation research and has the potential to generate data for pharmacoepidemiological studies. 
Similar software could be used to generate cross-national studies about antibiotic patterns in Africa. 
 
